Universal-Beteiligungs- und Servicegesellschaft’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$292K Sell
34,929
-48,427
-58% -$441K ﹤0.01% 1939
2026
Q1
$751K Buy
83,356
+32,085
+63% +$506K ﹤0.01% 1604
2025
Q4
$935K Buy
51,271
+2,346
+5% +$39.5K ﹤0.01% 1516
2025
Q3
$717K Sell
48,925
-196,326
-80% -$3.37M ﹤0.01% 1645
2025
Q2
$4.47M Sell
245,251
-9,967
-4% -$203K 0.01% 875
2025
Q1
$5.06M Buy
+255,218
New +$4.41M 0.01% 798

Other funds holding ADMA

Universal-Beteiligungs- und Servicegesellschaft's ADMA Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its ADMA Biologics (ADMA) stake by 58% in Q2 2026, selling an estimated $441K and leaving 34,929 shares worth $292K. The position accounts for ﹤0.01% of the portfolio, ranked #1939.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in ADMA in Q1 2025 and has held it in 6 quarters since. The position peaked at $5.06M in Q1 2025. 212 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 34,929 shares of ADMA Biologics worth $292K as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft sold 48,427 ADMA Biologics shares in Q2 2026, an estimated $441K.
  • ADMA Biologics made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1939 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in ADMA Biologics in Q1 2025 and has held it in 6 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's ADMA Biologics position peaked at $5.06M in Q1 2025.
  • 212 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.